- Trials with a EudraCT protocol (4)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (0)
4 result(s) found for: Alastrim.
Displaying page 1 of 1.
EudraCT Number: 2010-018334-51 | Sponsor Protocol Number: POX-MVA-032 | Start Date*: 2010-07-15 | ||||||||||||||||
Sponsor Name:Bavarian Nordic A/S | ||||||||||||||||||
Full Title: An open-label, non-controlled study to immunize healthy volunteers actively working with or in the vicinity of replicating Vaccinia virus with IMVAMUNE® (MVA-BN®) | ||||||||||||||||||
Medical condition: Healthy subjects actively working with or in the vicinity of replicating Vaccinia virus will receive immunization IMVAMUNE to offer protection against accidential Vaccinia virus infection. | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults | Gender: Male, Female | |||||||||||||||||
Trial protocol: DE (Prematurely Ended) | ||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2012-005137-37 | Sponsor Protocol Number: POX-MVA-035 | Start Date*: 2013-07-15 | |||||||||||
Sponsor Name:Bavarian Nordic A/S | |||||||||||||
Full Title: Open-label, non-controlled, multicenter immunogenicity and safety study of MVA-BN® smallpox vaccine in children from birth to less than 12 years of age | |||||||||||||
Medical condition: Prevention of smallpox infection in children | |||||||||||||
|
|||||||||||||
Population Age: Newborns, Infants and toddlers, Children, Under 18 | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2005-001781-14 | Sponsor Protocol Number: POX-MVA-005 | Start Date*: 2006-04-11 | |||||||||||
Sponsor Name:Bavarian Nordic A/S | |||||||||||||
Full Title: A partially randomized, partially double-blind, placebo-controlled Phase II non-inferiority study to evaluate immunogenicity and safety of one and two doses of MVA-BN (IMVAMUNE™) smallpox vaccine i... | |||||||||||||
Medical condition: Healthy subjects - prevention of smallpox infection | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2007-006297-28 | Sponsor Protocol Number: POX-MVA-023 | Start Date*: 2008-07-30 | |||||||||||
Sponsor Name:Bavarian Nordic A/S | |||||||||||||
Full Title: An open-label Phase II study to evaluate immunogenicity and safety of a single IMVAMUNE® booster vaccination two years after the last IMVAMUNE® vaccination in former POX-MVA-005 vaccinees | |||||||||||||
Medical condition: Healthy subjects - prevention of smallpox infection | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Completed) | |||||||||||||
Trial results: View results |
Subscribe to this Search
To subscribe to the RSS feed for this search click here . This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here . This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
Query did not match any studies.